Despite movements promoting body positivity and “fat acceptance”, new drugs that can result in people losing up to 20 per cent of their body weight have been met by overwhelming demand.
The diabetes drug Ozempic has experienced worldwide shortages this year as an off-label weight loss tool, highlighting the huge popularity of pharmaceutical weight loss treatments.
It’s likely to be just the beginning of a new wave of much-hyped drugs, according to obesity expert Professor Michael Cowley of Monash University in Melbourne.
